Ranibizumab Intraocular and Tolterodine Extended-Release Capsules
Determining the interaction of Ranibizumab Intraocular and Tolterodine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: tolterodine
Brand name: Detrol, Detrol LA
Synonyms: Tolterodine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Tolterodine Tablets
- Ranibizumab Intraocular-Tolterodine Tartrate
- Ranibizumab Intraocular-Tolterodine Tartrate Capsules
- Ranibizumab Intraocular-Tolterodine Tartrate Tablets
- Ranibizumab Intraocular-Tolvaptan
- Ranibizumab Intraocular-Tolvaptan (Jynarque/Jinarc)
- Tolterodine Extended-Release Capsules-Ranibizumab ophthalmic
- Tolterodine Extended-Release Capsules-Ranitidine
- Tolterodine Extended-Release Capsules-Ranitidine Capsule
- Tolterodine Extended-Release Capsules-Ranitidine Hydrochloride
- Tolterodine Extended-Release Capsules-Ranitidine Injection
- Tolterodine Extended-Release Capsules-Ranitidine Suspension